Literature DB >> 2661051

Endothelium-derived relaxing factor and coronary vasospasm.

P M Vanhoutte1, H Shimokawa.   

Abstract

The endothelium releases the powerful vasodilator and antiaggregatory substance, EDRF, both under basal conditions and upon stimulation by a wide variety of agents. Endothelial injury or dysfunction may play an important role in the spasmogenicity of the coronary artery, although other possible alterations related to atherosclerosis should also be considered. Among the possible stimuli, aggregating platelets are important as a source of vasoconstrictor substances. The endothelium may also produce the vasoactive substances EDHF and EDCF(s). Their pathophysiologic significance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661051     DOI: 10.1161/01.cir.80.1.1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  49 in total

Review 1.  Life insurance implications of mortality for up to 40 years after repair of congenital heart defects in childhood.

Authors:  G R Cumming
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  Urgent homograft aortic root replacement for aortic root abscess in infants and children.

Authors:  R Chaturvedi; M de Leval; I D Sullivan
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  Graft vascular disease in heart transplant patients.

Authors:  J Mann
Journal:  Br Heart J       Date:  1992-09

Review 4.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

5.  Prognostic significance of ST-T segment alterations in patients with non-Q wave myocardial infarction.

Authors:  J A Ramires; C V Serrano; M C Solimene; P J Moffa; B Caramelli; F Pileggi
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 6.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

Review 7.  Pathogenesis of atherosclerosis: state of the art.

Authors:  C C Haudenschild
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

8.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

9.  Cardiorespiratory exercise performance after Senning operation for transposition of the great arteries.

Authors:  T Reybrouck; M Gewillig; M Dumoulin; L G van der Hauwaert
Journal:  Br Heart J       Date:  1993-08

Review 10.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.